Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2014 - 2026)
Atara Biotherapeutics (ATRA) reported Amortizatization of Intangibles of $814000.0 for Q1 2026, up 414.29% on a YoY basis from $158277.8 in Q1 2025, and up 1069.05% quarter-over-quarter from -$84000.0 in Q4 2025.
Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Atara Biotherapeutics has reported Amortizatization of Intangibles for 13 years, with the latest figure at $814000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 414.29% year-over-year to $814000.0; the trailing twelve-month figure through Mar 2026 stood at $814000.0 (down 70.97% YoY), and the FY2025 full-year result was -$259000.0, down 106.3% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $814000.0, up from -$84000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $4.1 million in Q4 2024, with the low at -$2.0 million in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $496000.0 across 5 years, with a median of $57000.0 in 2024.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 2226.0% — and 2025, when it tumbled 3580.7%.
- Atara Biotherapeutics' Amortizatization of Intangibles stood at -$50000.0 in 2022, then jumped by 2226.0% to $1.1 million in 2023, then soared by 283.73% to $4.1 million in 2024, then plunged by 102.06% to -$84000.0 in 2025, then soared by 1069.05% to $814000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $814000.0 (Q1 2026), -$84000.0 (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Atara Biotherapeutics | 139.68 Mn | 131.28 Mn | 392,000.00 | 814,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 814,000.00 |
| Mar 31, 2026 | 814,000.00 |
| Dec 31, 2025 | -84,000.00 |
| Dec 31, 2025 | -84,000.00 |
| Sep 30, 2025 | -1.98 Mn |
| Sep 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | -259,000.00 |
| Mar 31, 2025 | -259,000.00 |
| Dec 31, 2024 | 4.08 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |